Lance Baldo

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.

MedAptus, Inc. operates as a healthcare information technology company which provides revenue cycle solutions to medical group practices and integrated delivery systems. It offers professional charge capture a flexible, scalable solution in use at single-specialty groups, multi-specialty clinics, academic centers and IDNs; technical charge capture eases and standardizes facility billing by automating the charge creation process across an outpatient care team; and infusion services charge capture which streamline and improve infusion coding by compliant capture. The company was founded by Lance Baldo and Malcolm M. Lloyd in 1999 and is headquartered in Boston, MA.